On December 16, 2024, David Rokach, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was reported as a grant, award, or other acquisition.Following this transaction, Rokach directly owns 10,000 shares of Nukkleus common stock. The total value of the acquired shares amounts to $13,900. This acquisition suggests a potential alignment of the CEO's interests with those of the shareholders.The transaction has been completed and reported as required by securities regulations. This stock acquisition by the CEO may be viewed as a positive signal about the company's future prospects, although investors should consider it alongside other financial and market information.

On December 16, 2024, David Rokach, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was reported as a grant, award, or other acquisition.Following this transaction, Rokach directly owns 10,000 shares of Nukkleus common stock. The total value of the acquired shares amounts to $13,900. This acquisition suggests a potential alignment of the CEO's interests with those of the shareholders.The transaction has been completed and reported as required by securities regulations. This stock acquisition by the CEO may be viewed as a positive signal about the company's future prospects, although investors should consider it alongside other financial and market information.